Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBT Margin (2016 - 2025)

iBio (IBIO) has disclosed EBT Margin for 16 consecutive years, with 5720.0% as the latest value for Q3 2025.

  • Quarterly EBT Margin changed N/A to 5720.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 8245.67% through Dec 2025, down 418327.0% year-over-year, with the annual reading at 4594.25% for FY2025, 271375.0% up from the prior year.
  • EBT Margin for Q3 2025 was 5720.0% at iBio, down from 2581.5% in the prior quarter.
  • The five-year high for EBT Margin was 374.89% in Q1 2022, with the low at 10148.0% in Q3 2023.
  • Average EBT Margin over 5 years is 3646.65%, with a median of 2182.0% recorded in 2024.
  • Peak annual rise in EBT Margin hit 386940bps in 2021, while the deepest fall reached -506363bps in 2021.
  • Over 5 years, EBT Margin stood at 6901.19% in 2021, then skyrocketed by 95bps to 374.89% in 2022, then tumbled by -2607bps to 10148.0% in 2023, then surged by 78bps to 2182.0% in 2024, then tumbled by -162bps to 5720.0% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 5720.0%, 2581.5%, and 2182.0% for Q3 2025, Q2 2025, and Q4 2024 respectively.